Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4546160
Max Phase: Preclinical
Molecular Formula: C39H36N8O5S
Molecular Weight: 728.83
Molecule Type: Unknown
Associated Items:
ID: ALA4546160
Max Phase: Preclinical
Molecular Formula: C39H36N8O5S
Molecular Weight: 728.83
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1nnc2n1Cc1sc(C#Cc3cnn(CCCCCNc4cccc5c4C(=O)N(C4CCC(=O)NC4=O)C5=O)c3)c(Cc3ccccc3)c1OC2
Standard InChI: InChI=1S/C39H36N8O5S/c1-24-43-44-33-23-52-36-28(19-25-9-4-2-5-10-25)31(53-32(36)22-46(24)33)15-13-26-20-41-45(21-26)18-7-3-6-17-40-29-12-8-11-27-35(29)39(51)47(38(27)50)30-14-16-34(48)42-37(30)49/h2,4-5,8-12,20-21,30,40H,3,6-7,14,16-19,22-23H2,1H3,(H,42,48,49)
Standard InChI Key: CHKQAJSLHRGWNU-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 728.83 | Molecular Weight (Monoisotopic): 728.2529 | AlogP: 4.46 | #Rotatable Bonds: 10 |
Polar Surface Area: 153.34 | Molecular Species: NEUTRAL | HBA: 12 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 13 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 11.59 | CX Basic pKa: 2.63 | CX LogP: 4.31 | CX LogD: 4.31 |
Aromatic Rings: 5 | Heavy Atoms: 53 | QED Weighted: 0.12 | Np Likeness Score: -0.86 |
1. Qin C, Hu Y, Zhou B, Fernandez-Salas E, Yang CY, Liu L, McEachern D, Przybranowski S, Wang M, Stuckey J, Meagher J, Bai L, Chen Z, Lin M, Yang J, Ziazadeh DN, Xu F, Hu J, Xiang W, Huang L, Li S, Wen B, Sun D, Wang S.. (2018) Discovery of QCA570 as an Exceptionally Potent and Efficacious Proteolysis Targeting Chimera (PROTAC) Degrader of the Bromodomain and Extra-Terminal (BET) Proteins Capable of Inducing Complete and Durable Tumor Regression., 61 (15): [PMID:30019901] [10.1021/acs.jmedchem.8b00506] |
Source(1):